AbbVie, Inc. (ABBV)
294.45
-0.53
(-0.18%)
USD |
NYSE |
Nov 12, 16:00
295.52
+1.07
(+0.36%)
Pre-Market: 04:13
AbbVie Price : 294.45 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 299.30 | 300.42 | 294.07 | 294.45 | 4.827M |
| Nov 11, 2026 | 291.36 | 295.46 | 289.72 | 294.98 | 3.262M |
| Nov 10, 2026 | 292.50 | 294.50 | 291.04 | 293.89 | 3.521M |
| Nov 09, 2026 | 293.84 | 294.57 | 289.59 | 293.30 | 5.867M |
| Nov 06, 2026 | 282.27 | 291.73 | 281.07 | 291.31 | 5.041M |
| Nov 05, 2026 | 298.74 | 302.93 | 287.71 | 288.24 | 7.971M |
| Nov 04, 2026 | 293.95 | 295.40 | 283.32 | 294.83 | 8.435M |
| Nov 03, 2026 | 288.69 | 291.32 | 284.70 | 286.00 | 5.368M |
| Nov 02, 2026 | 290.38 | 294.86 | 286.14 | 288.84 | 8.850M |
| Oct 30, 2026 | 292.00 | 298.74 | 291.01 | 294.89 | 6.898M |
| Oct 29, 2026 | 291.00 | 292.67 | 288.04 | 290.79 | 4.329M |
| Oct 28, 2026 | 282.93 | 288.80 | 281.22 | 285.99 | 3.111M |
| Oct 27, 2026 | 283.88 | 287.32 | 283.12 | 286.39 | 3.269M |
| Oct 26, 2026 | 287.05 | 289.59 | 285.18 | 286.74 | 4.516M |
| Oct 23, 2026 | 284.58 | 286.76 | 282.30 | 285.64 | 4.632M |
| Oct 22, 2026 | 284.57 | 285.76 | 278.01 | 285.19 | 6.173M |
| Oct 21, 2026 | 287.63 | 289.00 | 282.15 | 284.80 | 4.395M |
| Oct 20, 2026 | 286.90 | 290.98 | 285.00 | 289.08 | 5.176M |
| Oct 19, 2026 | 284.23 | 287.93 | 282.59 | 282.68 | 4.172M |
| Oct 16, 2026 | 283.61 | 286.64 | 282.96 | 285.42 | 5.777M |
| Oct 15, 2026 | 288.28 | 291.40 | 282.81 | 283.40 | 7.622M |
| Oct 14, 2026 | 277.00 | 285.40 | 275.97 | 283.48 | 5.633M |
| Oct 13, 2026 | 283.29 | 283.43 | 273.70 | 274.36 | 6.410M |
| Oct 12, 2026 | 277.65 | 281.30 | 276.01 | 281.12 | 5.594M |
| Oct 09, 2026 | 271.53 | 277.60 | 270.38 | 276.47 | 4.298M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 250.48 |
| Gilead Sciences, Inc. | 167.95 |
| Regeneron Pharmaceuticals, Inc. | 951.19 |
| Amgen, Inc. | 467.06 |
| REGENXBIO, Inc. | 8.03 |
Price Related Metrics
| PE Ratio | 50.68 |
| PS Ratio | 7.907 |
| PEG Ratio | 0.1497 |
| Price to Free Cash Flow | 27.66 |
| Earnings Yield | 1.97% |
| Market Cap | 520.44B |
| PEGY Ratio | 0.1487 |
| Operating PE Ratio | 21.85 |
| Normalized PE Ratio | 31.42 |